Exelixis Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.6% | -11.3% | +49.8% | -15.3% | +5.0% | -2.0% | +2.3% | +5.2% | +0.2% | +2.0% | +2.9% | – | |
| – | +15.9% | -2.3% | -16.9% | -1.9% | +15.2% | -4.0% | +1.6% | -4.6% | +42.6% | -24.7% | +3.5% | – | |
| – | +1.0% | -11.8% | +53.4% | -15.7% | +4.7% | -1.9% | +2.3% | +5.5% | -1.2% | +3.3% | +2.9% | – | |
| – | -26.4% | -6.9% | -7.3% | +5.4% | +11.9% | -14.8% | -5.6% | -0.6% | +7.1% | -6.3% | +6.0% | – | |
| – | -33.8% | +24.7% | +15.8% | -15.3% | -18.8% | +51.0% | -1.7% | -8.3% | -42.3% | +95.7% | +5.8% | – | |
| – | -20.1% | -0.4% | -8.2% | +12.4% | -0.7% | -8.9% | -4.1% | +2.2% | -1.7% | +0.8% | +5.9% | – | |
| – | – | -64.0% | +836.4% | -50.7% | +19.9% | +14.5% | +14.3% | +10.8% | -0.6% | +6.9% | -1.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,671.0% | -52.2% | +494.4% | -47.2% | +19.4% | +11.3% | +12.0% | +9.5% | +0.1% | +5.9% | -1.9% | – | |
| – | +266.8% | -31.8% | +458.4% | -44.9% | +22.1% | +2.6% | -1.1% | +29.1% | -86.1% | +601.2% | -11.5% | – | |
| – | +8,115.0% | -56.4% | +505.9% | -47.8% | +18.6% | +14.1% | +15.8% | +4.7% | +26.3% | -13.9% | +0.8% | – | |
| – | +804.4% | -37.3% | +313.1% | -31.2% | -12.4% | +24.5% | +11.6% | +9.3% | -6.5% | +13.1% | -4.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.